Hypogonadotropic hypogonadism in human immunodeficiency virus-infected men: uncommonly low testosterone levels

Abstract

Hypogonadotropic hypogonadism (HH) is common and occurs prematurely in HIV-infected men. However, HH with very low testosterone has not been described. Three men with normal pubertal development and HIV1 diagnosis at the ages of 22, 34 and 35 years. All complained of decreased libido, anejaculation and erectile dysfunction thirteen years, six months and one year after HIV diagnosis, respectively. Two had depressive syndrome and two were treated with antiretroviral therapy. Laboratory tests revealed isolated HH in all. Sellar and head CT scans were normal and all had normal CD4 count. They started testosterone replacement therapy, with symptoms improvement. Causes of HH in HIV-infected men include undernutrition, severe illness, drugs, pituitary dysfunction and comorbidities. Despite having none of these conditions (except two that were treated with low-dose psychotropics), our patients had HH with uncommonly low testosterone. This suggests that a different mechanism contributes to severe HH in HIV-infected men.Learning points:The pathogenesis of hypogonadotropic hypogonadism in HIV-infected men is multifactorial and androgen deficiency is more often a consequence of secondary hypogonadism than primary hypogonadism.Causes of hypogonadotropic hypogonadism in HIV-infected men include undernutrition, severe illness, drugs (psychotropics, opiates, megestrol acetate or steroids), pituitary dysfunction (tumor, hyperprolactinemia), an AIDS-related lesion (very rarely) and comorbid conditions, such as antibody to hepatitis C virus seropositivity and injection drug use.Highly active antiretroviral therapy (HAART), particularly protease inhibitor therapy has been associated with sexual dysfunction in men, but the causal nature of this relation has not been clearly established.Hypogonadotropic hypogonadism with uncommonly low testosterone levels are not usually associated with the conditions referred and this suggests that a different mechanism could contribute to severe hypogonadotropic hypogonadism in HIV-infected men.Screening for hypogonadism in all HIV-infected men might help to understand its etiology.

Severely low testosterone in males with COVID‐19: A case‐control study

“…Here, we hypothesize that the virus-host interaction mechanism in males is different, and more acutely linked to SARS-CoV-2 infection per se. Indeed, a sex different sensitivity of the hypothalamic-pituitary-gonadal (HPG) to inflammation 6,41,42 could induce an acute and dramatic drop in circulating tT in SARS-CoV-2 infected males, and the subsequent hypogonadal condition may trigger serious or an even fatal course of the disease. [28][29][30] According to our speculation, published data showed that circulating tT levels may be negatively affected by unmodifiable conditions (ie, age), 27,35 chronic conditions (ie, obesity, systemic diseases, and overall health status), 35,41 but also by acute illness, 35 including acute viral infections.…”

Could SARS‐CoV‐2 affect male fertility?

“…Furthermore, a study on testicular autopsy reported the gradual destruction of germ cells in extended AIDS survival (Shevchuk, Pigato, Khalife, Armenakas, & Fracchia, 1999). Males who used more advanced immunosuppressants had reduced levels of total serum testosterone, caused by secondary hypogonadism (Gomes, Aragüés, Guerra, Fernandes, & Mascarenhas, 2017), and the latter is one of the significant endocrine disorders causing infertility in men with AIDS (Wong, Levy, & Stephenson, 2017).…”

Allopregnanolone and neuroHIV: Potential benefits of neuroendocrine modulation in the era of antiretroviral therapy

“…As a result, PLWH are commonly affected by disruptions to the hypothalamic-pituitary-adrenal (HPA) and -gonadal (HPG) axes. 91,92…”